Further studies are warranted to investigate the mechanisms underlying the TRF-mediated anti-tumor effect and to explore the therapeutic efficacy of combination treatment of TRF and TIM inhibition or plus chemotherapy in patients with cancer. Here, TIMELESS is linked to neoplasm.